Prospective Clinical Study of Retinal Microvascular Alteration After ICL Implantation
Sponsor: Peking University Third Hospital
This observational or N/A phase trial investigates Adolescent and Adult and is currently completed. Peking University Third Hospital leads this study, which shows 4 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jul 2020 — Jan 2021 [monthly]
Completed
First recorded
Nov 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Peking University Third Hospital
For direct contact, visit the study record on ClinicalTrials.gov .